LRP和MRP在肺癌中表达及其临床意义

    Expression and clinical significance of lung resistance related protein and multidrug resistance in lung cancer

    • 摘要: 目的:研究肺耐药相关蛋白(lung resistance related protein,LRP)、多药耐药相关蛋白(multidrug resistance,MRP)在肺癌中的表达及其临床意义。方法:免疫组织化学法检测62例肺癌组织LRP和MRP的表达情况。结果:62例肺癌组织中LRP、MRP的表达率分别为61.3%和70.0%,LRP和MRP共同阳性表达率为51.6%,LRP、MRP的阳性表达率在肺癌患者的年龄、性别、病理类型、分化程度及TNM分期差异均无统计学意义(P>0.05),且两者之间无相关关系(P>0.05)。结论:LRP、MRP与肺癌的固有性耐药有关,与肺癌的临床病理特征无明显关系,且两者在肺癌组织中的表达无相关关系。

       

      Abstract: Objective:To investigate the expression and clinical significance of lung resistance related protein (LRP) and multidrug resistance associated protein (MRP) in lung cancer.Methods:Sixty two cases of lung cancer were detected of the presence of LRP and MRP by immunohistochemical analysis.Results:The expression of LRP and MRP,in lung cancer was 61.3% and 70.0% respectively,and their common positive expression was 51.6%.The expreesion of LRP and MRP had no significant diffrerence in the clinicopathological variables including age,sex,pathology type,differentiation degree or TNM stage (P>0.05).In addition,LRP had no correlation with MRP (P>0.05).Conclusions:The expression of LRP and MRP is related with lung cancer's intrinsic drug resistance,but not obviously coorelated with the clinicopathological characteristics.There is no correlation between LRP and MRP.

       

    /

    返回文章
    返回